Free intracellular calcium in peripheral cells in Alzheimer's disease

Neurobiology of Aging

Volumn 18, Issue 3, 1997, Pages 281-284

  Eckert, A ^a   Forstl H ^a   Zerfass, R ^c   Hennerici, M ^b   Muller W E ^a  

^a Ctrl Institute of Mental Health J5   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c NONE

Author keywords

Alzheimer's disease; Free intracellular calcium; Lymphocytes; Neutrophils; Amyloid

Indexed keywords

AMYLOID BETA PROTEIN;

ADULT; ALZHEIMER DISEASE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; NERVE DEGENERATION; PATHOGENESIS; PERIPHERAL LYMPHOCYTE; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN FIBROBLAST;

EID: 0343247764     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(97)80308-9     Document Type: Article

References (27)

1. Adunsky A., Baram D., Hershkowitz M., Mekori Y. A. Increased cytosolic calcium in lymphocytes of Alzheimer patients. J. Neuroimmunol. 33:1991;167-172.
2. Araga S., Kagimoto H., Funamoto K., Takahashi K. Lymphocyte proliferation and subpopulations in dementia of the Alzheimer's type. Jpn. J. Med. 29:1990;572-575.
3. Bondy B., Hofmann M., Müller-Spahn F., Witzko M., Hock Ch. Reduced β-amyloid response in lymphocytes of patients with Alzheimer's disease. Pharmacopsychiatry. 28:1995;143-146.
4. + channels in Alzheimer's disease. J. Psychiatr. Res. 30:1996;217-227.
5. Cotman C. W., Pike C. J. β-Amyloid and its contriibution to neurodegeneration in Alzheimer's disease. Terry R. D., Katzmann R., Bick K. L. Alzheimer's disease. 1994;305-315 Raven Press, Ltd. New York.
6. Dysken M. W., Minichielleo M. D., Hill J. L., Skare S., Little J. T., Molchan S. E., Sunderland T. Distribution of peripheral lymphocytes in Alzheimer patients and controls. J. Psychiatr. Res. 26:1992;213-218.
7. Eckert A., Hartmann H., Müller W. E. β-Amyloid protein enhances the mitogen-induced calcium response in circulating human lymphocytes. FEBS Lett. 330:1993;49-52.
8. Eckert A., Förstl H., Hartmann H., Müller W. E. Decreased β-amyloid sensitivity in Alzheimer's disease. Lancet. 342:1993;805-806.
9. Eckert A., Hartmann H., Förstl H., Müller W. E. Alterations of intracellular calcium regulation during aging and Alzheimer's disease in nonneuronal cells. Life Sci. 55:1994;2019-2029.
10. Eckert A., Förstl H., Hartmann H., Czech C., Mönning U., Beyreuther K., Müller W. E. The amplifying effect of β-amyloid on cellular calcium signalling is reduced in Alzheimer's disease. Neuroreport. 6:1995;1199-1202.
11. Eckert A., Förstl H., Zerfass R., Hartmann H., Müller W. E. Lymphocytes and neutrophils as peripheral models to study the effect of β-amyloid on cellular calcium signalling in Alzheimer's disease. Life Sci. 59:1996;499-510.
12. Förstl H., Besthorn C., Geiger-Kabisch C., Sattel H., Schreiter-Gasser U. Psychotic features and the course of Alzheimer's disease: Relationship to cognitive, EEG and CT-Scan findings. Acta Psychiatr. Scand. 87:1993;395-399.
13. 4 binding in Alzheimer's disease brain. Brain Res. 681:1995;160-166.
14. Gibson G. E., Toral-Barza L. Cytosolic free calcium in lymphoblasts from young, aged and Alzheimer's subjects. Mech. Ageing Dev. 63:1992;1-9.
15. Govoni S., Bergamaschi S., Racchi M., Battaini F., Binetti G., Bianchetti A., Trabucchi M. Cytosol protein kinase C downregulation in fibroblasts from Alzheimer's disease patients. Neurology. 43:1993;2581-2586.
16. + lymphocytes in Alzheimer's disease and in older persons with Down's syndrome. Neurobiol. Aging. 14:1993;177-185.
17. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:1985;3440-3450.
18. Hartmann H., Eckert A., Müller W. E. β-Amyloid amplifies calcium signalling in central neurons from the adult mouse. Biochem. Biophys. Res. Commun. 194:1993;1216-1220.
19. Hartmann H., Eckert A., Förstl H., Müller W. E. Similar age-related changes of free intracellular calcium in lymphocytes and central neurons: Effects of Alzheimer's disease. Eur. Arch. Psychiatr. Clin. Neurosci. 243:1994;218-223.
20. Huang H.-M., Lin T.-A., Sun G. Y., Gibson G. E. Increased inositol 1,4,5-trisphosphate accumulation correlates with an upregulation of bradykinin receptors in Alzheimer's disease. J. Neurochem. 64:1995;761-766.
21. 2+ mobilization is altered in fibroblasts from patients with Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 91:1994;534-538.
22. Joseph R., Han E. Amyloid β-protein fragment 25-35 causes activation of cytoplasmic calcium in neurons. Biochem. Biophys. Res. Commun. 184:1992;1441-1447.
23. 2+ in human neutrophils responses to receptor agonists. Biochem. J. 278:1991;705-711.
24. Scott R. B. Extraneuronal manifestations of Alzheimer's disease. Geriatr. Biosci. 41:1993;268-276.
25. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlossmacher M., Whaley J., Swindlehurst C., McCormack R., Wolfert R., Selkoe D., Liederburg I., Schenk D. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature. 359:1992;325-328.
26. Singh V. K. Studies of neuroimmune markers in Alzheimer's disease. Mol. Neurobiol. 9:1994;73-81.
27. 2+ stores. Proc. Natl. Acad. Sci. USA. 90:1993;6295-6299.